Annual ROE
57.54%
+57.52%+287600.00%
December 31, 2023
Summary
- As of February 7, 2025, PBYI annual return on equity is 57.54%, with the most recent change of +57.52% (+287600.00%) on December 31, 2023.
- During the last 3 years, PBYI annual ROE has risen by +1099.84% (+105.52%).
- PBYI annual ROE is now -95.17% below its all-time high of 1190.76%, reached on December 31, 2021.
Performance
PBYI ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
44.22%
+24.59%+125.27%
September 30, 2024
Summary
- As of February 7, 2025, PBYI quarterly return on equity is 44.22%, with the most recent change of +24.59% (+125.27%) on September 30, 2024.
- Over the past year, PBYI quarterly ROE has increased by +30.83% (+230.25%).
- PBYI quarterly ROE is now -99.91% below its all-time high of 47.79 thousand%, reached on September 30, 2011.
Performance
PBYI Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PBYI ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10000.0% | +230.3% |
| 3 y3 years | +105.5% | +111.0% |
| 5 y5 years | +122.2% | +111.0% |
PBYI ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -95.2% | >+9999.0% | -67.9% | +107.2% |
| 5 y | 5-year | -95.2% | +105.5% | -67.9% | +105.2% |
| alltime | all time | -95.2% | +100.3% | -99.9% | +100.3% |
Puma Biotechnology ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 44.22%(+125.3%) |
| Jun 2024 | - | 19.63%(-49.1%) |
| Mar 2024 | - | 38.55%(-39.3%) |
| Dec 2023 | 57.54%(>+9900.0%) | 63.49%(+374.2%) |
| Sep 2023 | - | 13.39%(-231.5%) |
| Jun 2023 | - | -10.18%(-140.9%) |
| Mar 2023 | - | 24.90%(>+9900.0%) |
| Dec 2022 | 0.02%(-100.0%) | 0.01%(-100.0%) |
| Sep 2022 | - | 137.82%(-134.4%) |
| Jun 2022 | - | -401.08%(-35.0%) |
| Mar 2022 | - | -616.85%(+13.0%) |
| Dec 2021 | 1190.76%(-214.2%) | -545.87%(-35.3%) |
| Sep 2021 | - | -844.02%(+203.1%) |
| Jun 2021 | - | -278.48%(-10.1%) |
| Mar 2021 | - | -309.88%(-54.7%) |
| Dec 2020 | -1042.30%(+256.9%) | -684.27%(+63.1%) |
| Sep 2020 | - | -419.59%(+79.8%) |
| Jun 2020 | - | -233.32%(-38.2%) |
| Mar 2020 | - | -377.26%(+33.9%) |
| Dec 2019 | -292.05%(+12.6%) | -281.67%(-3.6%) |
| Sep 2019 | - | -292.33%(+16.3%) |
| Jun 2019 | - | -251.43%(+11.1%) |
| Mar 2019 | - | -226.29%(-8.6%) |
| Dec 2018 | -259.28%(+16.8%) | -247.68%(-7.6%) |
| Sep 2018 | - | -268.04%(-11.1%) |
| Jun 2018 | - | -301.35%(-4.1%) |
| Mar 2018 | - | -314.08%(+12.9%) |
| Dec 2017 | -221.91%(+68.7%) | -278.07%(+33.3%) |
| Sep 2017 | - | -208.53%(+6.1%) |
| Jun 2017 | - | -196.54%(+5.3%) |
| Mar 2017 | - | -186.69%(+0.3%) |
| Dec 2016 | -131.54% | -186.18%(+3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | -179.96%(+28.7%) |
| Jun 2016 | - | -139.84%(+20.8%) |
| Mar 2016 | - | -115.79%(+24.6%) |
| Dec 2015 | -116.15%(-4.2%) | -92.93%(-2.9%) |
| Sep 2015 | - | -95.66%(-0.1%) |
| Jun 2015 | - | -95.72%(+0.0%) |
| Mar 2015 | - | -95.68%(+5.2%) |
| Dec 2014 | -121.29%(+86.4%) | -90.93%(+21.7%) |
| Sep 2014 | - | -74.69%(+14.4%) |
| Jun 2014 | - | -65.27%(+26.1%) |
| Mar 2014 | - | -51.74%(-4.4%) |
| Dec 2013 | -65.08%(+12.8%) | -54.11%(+0.2%) |
| Sep 2013 | - | -54.01%(-32.1%) |
| Jun 2013 | - | -79.51%(-24.0%) |
| Mar 2013 | - | -104.57%(-26.7%) |
| Dec 2012 | -57.68%(+206.5%) | -142.61%(-23.3%) |
| Sep 2012 | - | -185.92%(+58.0%) |
| Jun 2012 | - | -117.67%(+29.3%) |
| Mar 2012 | - | -90.98%(+20.8%) |
| Dec 2011 | -18.82%(-98.7%) | -75.29%(-100.2%) |
| Sep 2011 | - | 47.79 K%(+244.9%) |
| Jun 2011 | - | 13.85 K%(-1329.0%) |
| Mar 2011 | - | -1127.27%(+77.1%) |
| Dec 2010 | -1400.00%(-91.7%) | -636.36%(-53.2%) |
| Sep 2010 | - | -1360.00%(-50.4%) |
| Jun 2010 | - | -2740.00%(-82.3%) |
| Mar 2010 | - | -15.50 K%(-667.7%) |
| Dec 2009 | -16.80 K%(-2721.3%) | - |
| Sep 2009 | - | 2730.43%(+33.2%) |
| Jun 2009 | - | 2050.00%(+70.8%) |
| Mar 2009 | - | 1200.00%(+87.2%) |
| Dec 2008 | 640.91% | 640.91% |
FAQ
- What is Puma Biotechnology annual return on equity?
- What is the all time high annual ROE for Puma Biotechnology?
- What is Puma Biotechnology annual ROE year-on-year change?
- What is Puma Biotechnology quarterly return on equity?
- What is the all time high quarterly ROE for Puma Biotechnology?
- What is Puma Biotechnology quarterly ROE year-on-year change?
What is Puma Biotechnology annual return on equity?
The current annual ROE of PBYI is 57.54%
What is the all time high annual ROE for Puma Biotechnology?
Puma Biotechnology all-time high annual return on equity is 1190.76%
What is Puma Biotechnology annual ROE year-on-year change?
Over the past year, PBYI annual return on equity has changed by +57.52% (+287600.00%)
What is Puma Biotechnology quarterly return on equity?
The current quarterly ROE of PBYI is 44.22%
What is the all time high quarterly ROE for Puma Biotechnology?
Puma Biotechnology all-time high quarterly return on equity is 47.79 K%
What is Puma Biotechnology quarterly ROE year-on-year change?
Over the past year, PBYI quarterly return on equity has changed by +30.83% (+230.25%)